Optimizing Signal Management in a Vaccine Adverse Event Reporting System: A Proof-of-Concept with COVID-19 Vaccines Using Signs, Symptoms, and Natural Language Processing
Article in Drug Safety (December 2023)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Pharmacovigilance in emerging economies: modeling interaction among barriers
Article in Journal of Advances in Management Research (June 2022)
Post-marketing safety surveillance of erenumab: new insight from Eudravigilance
Article in Expert Opinion on Drug Safety (March 2022)